Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIa, Single-Arm, Open Study of Apatinib and MASCT in Patients With Advanced Solid Tumors

NCT02844881 is registered in ClinicalTrials.gov with The First People's Hospital of Lianyungang as lead sponsor.

NCT NCT02844881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02844881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIa, Single-Arm, Open Study of Apatinib and MASCT in Patients With Advanced Solid Tumors
Lead sponsor
The First People's Hospital of Lianyungang
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 31, 2016
Completion date
July 31, 2018
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, excluding t cell lymphoma